[1]
|
NUCLEOTIDE SEQUENCE [MRNA], AND MUTAGENESIS.
TISSUE=Umbilical vein endothelial cell;
DOI=10.1016/0092-8674(95)90071-3; PubMed=7538907 [NCBI, ExPASy, EBI, Israel, Japan]
Chinnaiyan A.M.,
O'Rourke K.,
Tewari M.,
Dixit V.M.;
"FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis.";
Cell 81:505-512(1995).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA].
DOI=10.1074/jbc.270.14.7795; PubMed=7536190 [NCBI, ExPASy, EBI, Israel, Japan]
Boldin M.P.,
Varfolomeev E.E.,
Pancer Z.,
Mett I.L.,
Camonis J.H.,
Wallach D.;
"A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain.";
J. Biol. Chem. 270:7795-7798(1995).
|
[3]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Kalnine N.,
Chen X.,
Rolfs A.,
Halleck A.,
Hines L.,
Eisenstein S.,
Koundinya M.,
Raphael J.,
Moreira D.,
Kelley T.,
LaBaer J.,
Lin Y.,
Phelan M.,
Farmer A.;
"Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
|
[4]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Lung;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan] The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[5]
|
INTERACTION WITH PEA15.
DOI=10.1038/sj.onc.1202831; PubMed=10442631 [NCBI, ExPASy, EBI, Israel, Japan]
Condorelli G.,
Vigliotta G.,
Cafieri A.,
Trencia A.,
Andalo P.,
Oriente F.,
Miele C.,
Caruso M.,
Formisano P.,
Beguinot F.;
"PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis.";
Oncogene 18:4409-4415(1999).
|
[6]
|
INTERACTION WITH LRDD.
DOI=10.1016/S0167-4838(00)00029-7; PubMed=10825539 [NCBI, ExPASy, EBI, Israel, Japan]
Telliez J.-B.,
Bean K.M.,
Lin L.-L.;
"LRDD, a novel leucine rich repeat and death domain containing protein.";
Biochim. Biophys. Acta 1478:280-288(2000).
|
[7]
|
IDENTIFICATION IN A COMPLEX WITH HIPK3 AND FAS, AND PHOSPHORYLATION AT SER-194.
DOI=10.1084/jem.192.8.1165; PubMed=11034606 [NCBI, ExPASy, EBI, Israel, Japan]
Rochat-Steiner V.,
Becker K.,
Micheau O.,
Schneider P.,
Burns K.,
Tschopp J.;
"FIST/HIPK3: a Fas/FADD-interacting serine/threonine kinase that induces FADD phosphorylation and inhibits Fas-mediated Jun NH2-terminal kinase activation.";
J. Exp. Med. 192:1165-1174(2000).
|
[8]
|
INTERACTION WITH MBD4.
DOI=10.1073/pnas.0431215100; PubMed=12702765 [NCBI, ExPASy, EBI, Israel, Japan]
Screaton R.A.,
Kiessling S.,
Sansom O.J.,
Millar C.B.,
Maddison K.,
Bird A.,
Clarke A.R.,
Frisch S.M.;
"Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: a potential link between genome surveillance and apoptosis.";
Proc. Natl. Acad. Sci. U.S.A. 100:5211-5216(2003).
|
[9]
|
INTERACTION WITH MAVS.
DOI=10.1038/ni1243; PubMed=16127453 [NCBI, ExPASy, EBI, Israel, Japan]
Kawai T.,
Takahashi K.,
Sato S.,
Coban C.,
Kumar H.,
Kato H.,
Ishii K.J.,
Takeuchi O.,
Akira S.;
"IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction.";
Nat. Immunol. 6:981-988(2005).
|
[10]
|
STRUCTURE BY NMR OF 1-83.
DOI=10.1038/31972; PubMed=9582077 [NCBI, ExPASy, EBI, Israel, Japan]
Eberstadt M.,
Huang B.,
Chen Z.,
Meadows R.P.,
Ng S.C.,
Zheng L.,
Lenardo M.J.,
Fesik S.W.;
"NMR structure and mutagenesis of the FADD (Mort1) death-effector domain.";
Nature 392:941-945(1998).
|
|